Hematology/Oncology

Top Story

Thyroid cancer risk increases with hysterectomy

July 29, 2016

Among postmenopausal women, the risk for thyroid cancer is increased with hysterectomy regardless of oophorectomy status, according to recently published data.

Use of exogenous estrogen was associated with lower risk for thyroid cancer in women who had undergone hysterectomy without oophorectomy, particularly for those with long duration use of hormone therapy, researchers wrote.

American Society of Breast Surgeons recommends against contralateral prophylactic mastectomy

July 29, 2016
The American Society of Breast Surgeons issued a position statement that recommends against contralateral prophylactic mastectomy for average-risk women with unilateral…
In the Journals Plus

Ovarian cancer surveillance with CA-125 tests, CT scans common despite lack of proven benefit

July 29, 2016
Cancer antigen 125 tests and CT scans are routinely used for surveillance of patients with ovarian cancer despite a lack of proven benefit, according to results of a…
In the Journals Plus

High-dose methotrexate improves outcomes in children with B-ALL

July 29, 2016
High-dose methotrexate appeared superior to Capizzi methotrexate without increasing toxicity in children and young adults with high-risk B-acute lymphoblastic leukemia…
In the Journals Plus

Melanoma screening increases detection with little impact on use of surgery, specialist referrals

July 28, 2016
Melanoma screening in the community medical setting increased melanoma diagnoses rates, but did not result in an upsurge of skin surgeries or dermatology office visits…
More News Headlines »
CME

Updates from Vienna 2015 – Highlights in Hematologic Malignancies

This activity is supported by an educational grant from Genentech, Inc.

The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a…
More »
Video
Meeting News Coverage

VIDEO: Adding rituximab to chemotherapy increases PFS in patients with CLL

July 8, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan